J 2017

Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients

MARUSIC, A.P., I. LOCATELLI, A. MRHAR, M. CAPRNDA, L. GASPAR et. al.

Basic information

Original name

Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients

Authors

MARUSIC, A.P. (705 Slovenia), I. LOCATELLI (705 Slovenia), A. MRHAR (705 Slovenia), M. CAPRNDA (703 Slovakia), L. GASPAR (705 Slovenia), M. ADAMEK (616 Poland), Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and D. PETROVIC (705 Slovenia)

Edition

Clinical and Applied Thrombosis-Hemostasis, Thousand Oaks, Sage Publications Inc. 2017, 1076-0296

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.852

RIV identification code

RIV/00216224:14110/17:00099909

Organization unit

Faculty of Medicine

UT WoS

000412901900006

Keywords in English

prevention of venous thromboembolism; red blood cells; vitamin K; blood replacement

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 15:27, Soňa Böhmová

Abstract

V originále

Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups (P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.